Literature DB >> 11114262

Neurotoxicity of the putative transmembrane domain of the prion protein.

S Haïk1, J M Peyrin, L Lins, M Y Rosseneu, R Brasseur, J P Langeveld, F Tagliavini, J P Deslys, C Lasmézas, D Dormont.   

Abstract

It has been shown recently that the generation of an abnormal transmembrane form of the prion protein ((Ctm)PrP) is involved in the neurodegeneration process during inherited and infectious prion diseases but a causative relationship has never been established. We wanted to know if and how the proposed transmembrane domain of PrP could induce neuronal dysfunction. Thus, we investigated the neurotoxic properties of two peptides whose sequences are encompassed within this domain. We show that PrP peptides 118-135 and 105-132 as well as an amidated more soluble peptide 105-132 induce the death of pure cortical neurons originating from normal and PrP knockout mice. This can be correlated with the high propensity of these peptides to insert stably into and to destabilize cell membranes. Through this study, we have identified a novel mechanism of neurotoxicity for PrP, which directly involves membrane perturbation; this mechanism is independent of fibril formation and probably corresponds to the effect of the transmembrane insertion of (Ctm)PrP. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11114262     DOI: 10.1006/nbdi.2000.0316

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  12 in total

1.  Heterologous stacking of prion protein peptides reveals structural details of fibrils and facilitates complete inhibition of fibril growth.

Authors:  Ronald S Boshuizen; Veronica Schulz; Michela Morbin; Giulia Mazzoleni; Rob H Meloen; Johannes P M Langedijk
Journal:  J Biol Chem       Date:  2009-03-19       Impact factor: 5.157

2.  Comparing the energy landscapes for native folding and aggregation of PrP.

Authors:  Derek R Dee; Michael T Woodside
Journal:  Prion       Date:  2016-05-03       Impact factor: 3.931

3.  Highly neurotoxic monomeric α-helical prion protein.

Authors:  Minghai Zhou; Gregory Ottenberg; Gian Franco Sferrazza; Corinne Ida Lasmézas
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-07       Impact factor: 11.205

4.  Prion propagation and toxicity occur in vitro with two-phase kinetics specific to strain and neuronal type.

Authors:  Samia Hannaoui; Layal Maatouk; Nicolas Privat; Etienne Levavasseur; Baptiste A Faucheux; Stéphane Haïk
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

5.  In vivo and in vitro neurotoxicity of the human prion protein (PrP) fragment P118-135 independently of PrP expression.

Authors:  Joëlle Chabry; Christiane Ratsimanohatra; Isabelle Sponne; Pierre-Paul Elena; Jean-Pierre Vincent; Thierry Pillot
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

6.  Using protein misfolding cyclic amplification generates a highly neurotoxic PrP dimer causing neurodegeneration.

Authors:  XiuJin Yang; LiFeng Yang; XiangMei Zhou; Sher Hayat Khan; HuiNuan Wang; XiaoMin Yin; Zhen Yuan; ZhiQi Song; WenYu Wu; DeMing Zhao
Journal:  J Mol Neurosci       Date:  2013-06-16       Impact factor: 3.444

7.  C-Abl tyrosine kinase mediates neurotoxic prion peptide-induced neuronal apoptosis via regulating mitochondrial homeostasis.

Authors:  Bo Pan; Lifeng Yang; Jin Wang; Yunsheng Wang; Jihong Wang; Xiangmei Zhou; Xiaomin Yin; Zhongqiu Zhang; Deming Zhao
Journal:  Mol Neurobiol       Date:  2014-02-08       Impact factor: 5.590

8.  Pathogenic mutations in the glycosylphosphatidylinositol signal peptide of PrP modulate its topology in neuroblastoma cells.

Authors:  Yaping Gu; Ajay Singh; Sharmila Bose; Neena Singh
Journal:  Mol Cell Neurosci       Date:  2008-01-26       Impact factor: 4.314

9.  In vitro and in vivo neurotoxicity of prion protein oligomers.

Authors:  Steve Simoneau; Human Rezaei; Nicole Salès; Gunnar Kaiser-Schulz; Maxime Lefebvre-Roque; Catherine Vidal; Jean-Guy Fournier; Julien Comte; Franziska Wopfner; Jeanne Grosclaude; Hermann Schätzl; Corinne Ida Lasmézas
Journal:  PLoS Pathog       Date:  2007-08-31       Impact factor: 6.823

10.  Squalestatin alters the intracellular trafficking of a neurotoxic prion peptide.

Authors:  Rona Wilson; Clive Bate; Ronald Boshuizen; Alun Williams; James Brewer
Journal:  BMC Neurosci       Date:  2007-11-22       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.